Zacks

Zacks Small Cap Analysis – TELO Reverses Injury in Progeria Cells – Model Slux

by

By Brad Sorensen, CFA NASDAQ:TELO READ THE FULL TELO RESEARCH REPORT Telomir Prescribed drugs (NASDAQ:TELO) is a preclinical stage biopharmaceutical firm creating a product designed to reverse organic growing older and degenerative ailments. Beforehand reported preclinical exams have proven proof that Telomir-1, the corporate’s major remedy, can lengthen telomeres and preliminary animal testing illustrates the … Read more

Zacks Small Cap Analysis – IMNN: Translational Knowledge from OVATION 2 Offered… – Model Slux

by
Zacks Small Cap Analysis – IMNN: Translational Knowledge from OVATION 2 Offered… – Model Slux

By David Bautz, PhD NASDAQ:IMNN READ THE FULL IMNN RESEARCH REPORT Enterprise Replace OVATION 2 Translational Knowledge Offered at ESMO On June 18, 2025, Imunon, Inc. (NASDAQ:IMNN) introduced the presentation of translational information from the OVATION 2 medical trial of IMNN-001 on the European Society for Medical Oncology (ESMO) Gynaecological Cancers Congress 2025. These outcomes … Read more

Zacks Small Cap Analysis – OTC Markets Hosts Digital Investor Presentation with Yuya Yoshida, Government Vice President and CFO of SBC Medical Group Holdings, and M. Marin, Senior Analyst at Zacks SCR – Model Slux

by

NASDAQ:SBC John Viglotti: Whats up and welcome to Digital Investor Conferences. On behalf of OTC Markets and our cohost, Zacks Small Cap Analysis. We’re more than happy you joined us for our subsequent presentation from SBC Medical Group Holdings. Their query and reply session shall be moderated by M. Marin, Senior Fairness Analysis Analyst with … Read more

Zacks Small Cap Analysis – AEMD: Digital Assembly With Administration, Upcoming Presentation of Information in Lengthy Covid – Model Slux

by
Zacks Small Cap Analysis – AEMD: Digital Assembly With Administration, Upcoming Presentation of Information in Lengthy Covid – Model Slux

By M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT AEMD CMO will current knowledge on Hemopurifier potential in Lengthy Covid at Keystone Symposium We met just about with medical therapeutic firm Aethlon Medical (NASDAQ:AEMD) this week and current our constructive takeaways on this notice. AEMD has had an summary accepted for poster presentation on … Read more

Zacks Small Cap Analysis – UHAL: U-Haul Holding Firm Reviews 4Q and full-year FY2025 Outcomes. Revenues have been above expectations within the seasonally sluggish 4Q, however the backside line was impacted by rising depreciation expense in addition to by decrease resale values for retired vans. Additionally, an Annual Evaluation of FY2025. – Model Slux

by
Zacks Small Cap Analysis – UHAL: U-Haul Holding Firm Reviews 4Q and full-year FY2025 Outcomes. Revenues have been above expectations within the seasonally sluggish 4Q, however the backside line was impacted by rising depreciation expense in addition to by decrease resale values for retired vans. Additionally, an Annual Evaluation of FY2025. – Model Slux

By Steven Ralston, CFA NYSE:UHAL READ THE FULL UHAL RESEARCH REPORT EXECUTIVE SUMMARY U-Haul Holding Firm (NYSE: UHAL) reported 4Q and full-year FY2025 outcomes on Might 28th after the shut. Revenues have been above expectations within the seasonally slowest quarter, however the backside line was impacted by rising depreciation expense from the upper costs paid … Read more

x